| Literature DB >> 26378496 |
Erica Carpenter1, David Issadore2,3, Jina Ko2.
Abstract
In the last several years, nanoscale vesicles that originate from tumor cells and which can be found circulating in the blood (i.e. exosomes and microvesicles) have been discovered to contain a wealth of proteomic and genetic information to monitor cancer progression, metastasis, and drug efficacy. However, the use of exosomes and microvesicles as biomarkers to improve patient care has been limited by their small size (30 nm-1 μm) and the extensive sample preparation required for their isolation and measurement. In this Critical Review, we explore the emerging use of micro and nano-technology to isolate and detect exosomes and microvesicles in clinical samples and the application of this technology to the monitoring and diagnosis of cancer.Entities:
Mesh:
Year: 2016 PMID: 26378496 PMCID: PMC4881422 DOI: 10.1039/c5an01610j
Source DB: PubMed Journal: Analyst ISSN: 0003-2654 Impact factor: 4.616